CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Friedberg Ezra M Director | Sale 10b5-1 | −293 | $20.51 | $6K | 82,292 |
| 2026-04-02 | Friedberg Ezra M Director | Sale 10b5-1 | −265 | $21.36 | $6K | 82,027 |
| 2026-04-02 | Pauls Matthew Director | Sale 10b5-1 | −415 | $20.52 | $9K | 15,521 |
| 2026-04-02 | Pauls Matthew Director | Sale 10b5-1 | −371 | $21.36 | $8K | 15,150 |
| 2026-04-02 | Greenleaf Peter Director | Sale 10b5-1 | −420 | $20.52 | $9K | 25,058 |
| 2026-04-02 | Greenleaf Peter Director | Sale 10b5-1 | −377 | $21.36 | $8K | 24,681 |
| 2025-12-23 | Einhorn Andrew J. Director | Grant or award | +12,000 | 12,000 | ||
| 2025-12-17 | LIGAND PHARMACEUTICALS INC Director | Returned to the company · Senior Secured Convertible Note | −0 | 0 | ||
| 2025-12-17 | LIGAND PHARMACEUTICALS INC Director | Grant or award · Senior Secured Convertible Note | +0 | |||
| 2025-12-10 | Pauls Matthew Director | Gift | −9,542 | 1,074 | ||
| 2025-11-25 | Friedberg Ezra M Director | Sale | −5,999 | $28.00 | $168K | 34,001 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −2,000 | $28.14 | $56K | 32,001 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −1 | $28.50 | $29 | 32,000 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −2,000 | $28.01 | $56K | 30,000 |
| 2025-11-13 | Malamut Richard Director | Grant or award | +2,454 | 8,904 | ||
| 2025-11-06 | LIGAND PHARMACEUTICALS INC Director | Grant or award · Senior Secured Convertible Note | +0 | $9,000,000.00 | $0 | |
| 2025-10-02 | Pauls Matthew Director | Option exercise | +2,123 | 10,616 | ||
| 2025-10-02 | Pauls Matthew Director | Option exercise · Restricted Stock Units | −2,123 | 14,862 | ||
| 2025-07-02 | Friedberg Ezra M Director | Grant or award | +19,108 | 82,585 | ||
| 2025-07-02 | Davis Todd C Director | Grant or award | +19,108 | 39,886 |
Page 2 of 6 · 115 trades